PAP

Persistent Asset Partners Portfolio holdings

AUM $208M
1-Year Est. Return 95.31%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+95.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$208M
AUM Growth
+$70M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
392
New
Increased
Reduced
Closed

Top Buys

1 +$8.43M
2 +$5.15M
3 +$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

1 +$4.82M
2 +$3.15M
3 +$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

1 Healthcare 56.04%
2 Technology 14.52%
3 Financials 12.06%
4 Communication Services 4.8%
5 Energy 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOR icon
226
Vor Biopharma
VOR
$810M
$141K 0.07%
+10,798
NAMS icon
227
NewAmsterdam Pharma
NAMS
$3.99B
$138K 0.07%
+3,948
KPTI icon
228
Karyopharm Therapeutics
KPTI
$194M
$135K 0.06%
+18,316
NKE icon
229
Nike
NKE
$68.2B
$134K 0.06%
2,100
-225
COHR icon
230
Coherent
COHR
$64.7B
$129K 0.06%
+700
TVTX icon
231
Travere Therapeutics
TVTX
$3.77B
$126K 0.06%
+3,291
AVGO icon
232
Broadcom
AVGO
$1.92T
$125K 0.06%
+360
BE icon
233
Bloom Energy
BE
$59.1B
$121K 0.06%
1,397
-2,789
AVR
234
Anteris Technologies
AVR
$590M
$116K 0.06%
23,317
DBVT
235
DBV Technologies
DBVT
$1.26B
$115K 0.06%
+6,019
CERT icon
236
Certara
CERT
$954M
$113K 0.05%
+12,791
MLTX icon
237
MoonLake Immunotherapeutics
MLTX
$1.32B
$112K 0.05%
+8,523
ADPT icon
238
Adaptive Biotechnologies
ADPT
$2.23B
$109K 0.05%
+6,689
BLTE
239
Belite Bio
BLTE
$6.61B
$108K 0.05%
+673
BBOT
240
BridgeBio Oncology
BBOT
$748M
$107K 0.05%
+8,585
FSLR icon
241
First Solar
FSLR
$20.5B
$103K 0.05%
393
-307
SRZN icon
242
Surrozen
SRZN
$363M
$98.5K 0.05%
+4,359
EYPT icon
243
EyePoint Inc
EYPT
$1.25B
$98.4K 0.05%
+5,387
XRAY icon
244
Dentsply Sirona
XRAY
$2.5B
$98.4K 0.05%
+8,605
INSW icon
245
International Seaways
INSW
$3.78B
$97.1K 0.05%
+2,000
CSTL icon
246
Castle Biosciences
CSTL
$759M
$95.8K 0.05%
+2,463
ENVA icon
247
Enova International
ENVA
$4.06B
$95.6K 0.05%
+608
DNLI icon
248
Denali Therapeutics
DNLI
$3.26B
$93.6K 0.05%
+5,670
NVST icon
249
Envista
NVST
$4.54B
$92.6K 0.04%
+4,264
PRQR icon
250
ProQR Therapeutics
PRQR
$210M
$91.2K 0.04%
45,154
+8,874